Clinical Trials Logo

Polycystic Ovary clinical trials

View clinical trials related to Polycystic Ovary.

Filter by:
  • None
  • Page 1

NCT ID: NCT05965908 Not yet recruiting - Polycystic Ovary Clinical Trials

Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome

Start date: July 30, 2023
Phase: Phase 3
Study type: Interventional

The aim of this study is to compare the hormonal, metabolic and clinical effects of metformin and liraglutide in infertile women with PCOs.

NCT ID: NCT05452642 Recruiting - Polycystic Ovary Clinical Trials

The Supporting Understanding of PCOS Education and Research (SUPER) Study

SUPER
Start date: August 15, 2022
Phase: N/A
Study type: Interventional

This research will test whether a Dietary Approaches to Stop Hypertension (DASH) or a very low-carbohydrate diet better improves outcomes like blood glucose control and body weight for adults with polycystic ovary syndrome. Participants will have screening (includes blood draw) and baseline testing with a continuous glucose monitor and a body composition scan (called a dual-energy x-ray absorptiometry or DEXA). Once these enrollment steps are completed and the participants will be randomized to one of two 12-month programs.

NCT ID: NCT05062135 Completed - Polycystic Ovary Clinical Trials

Progesterone Action on Endometrium of PCOS

Start date: February 10, 2014
Phase: N/A
Study type: Interventional

Objective: To study the influence of metabolic factors on the action of progesterone on the endometrium of women with PCOS. Design: A prospective open-label clinical trial. Setting: Participants were recruited from an outpatient reproductive endocrinology clinic at an academic tertiary medical care center from 2014 to 2019. Subjects: To assess the sole effect of progesterone (P4) on the endometrium we studied amenorrheic (cycles> 90 days) women with PCOS (n=23), comparing them to healthy eumenorrheic control women ( n=13). Intervention(s): All subjects underwent an endometrial biopsy (EB) in the follicular phase of the first study cycle. They were then treated with micronized P4 (400 mg/day x 10 days intravaginally) from days 14-28 of the cycle, and a second EB was performed between days 20-24 of the cycle (second phase). Main Outcome Measure(s): EB samples were analyzed under light microscopy for histomorphometric analysis.

NCT ID: NCT04448730 Completed - Obesity Clinical Trials

Polycystic Ovary Syndrome and BETATROPHIN

Start date: January 1, 2018
Phase:
Study type: Observational

This is an original study giving an information about the association body mass index, polycystic ovary syndrome and betatrophin.

NCT ID: NCT04231786 Completed - Breast Diseases Clinical Trials

Breast Ultrasonography and Polycystic Ovary Syndrome

Start date: January 14, 2020
Phase:
Study type: Observational [Patient Registry]

The results of the evaluation of breast ultrasonography results of patients with polycystic ovary syndrome diagnosis over 30 years of age will be evaluated. Patients admitted to the outpatient clinic and rotterdam criteria according to laboratory data and polycystic ovary syndrome patients diagnosed by the same radiologist the next day after the end of menstrual breast ultrasonography. The aim of this study is to show the association of polycystic ovary syndrome and fibrocystic breast.

NCT ID: NCT03871868 Completed - Clinical trials for Vitamin D Deficiency

Vitamin D Levels And Myoma Uteri

Start date: December 1, 2018
Phase:
Study type: Observational

Women with at least one uterine leiomyoma and polycystic ovary syndrome over 10 mm and women with normal ultrasonographic findings were included in the study. Blood samples were taken for biochemical analysis such as vitamin D, calcium, magnesium, phosphorus, thyroid stimulating hormone (TSH), hemoglobin (hb), hematocrit (htc), platelet (plt), and albumin. The study groups were compared in terms of these biochemical markers and family history of patients, daily sunshine hours, clothing preferences and education level.

NCT ID: NCT03819998 Recruiting - Polycystic Ovary Clinical Trials

Serum Fetuin Level in Polycystic Ovary Syndrome

Start date: January 30, 2019
Phase:
Study type: Observational

polycystic ovary syndrome is a common gynecological problem

NCT ID: NCT03178500 Recruiting - Polycystic Ovary Clinical Trials

Clomiphene Citrate Stair-Step Protocol

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

A RCT will be conducted to compare the traditional clomiphene citrate regimens for ovulation induction with the stair-step protocol. Sixty women will be included after obtaining their written informed consent and will be randomized into either of the 2 groups.

NCT ID: NCT02087410 Not yet recruiting - Polycystic Ovary Clinical Trials

Serum Ghrelin in Polycystic Ovary Syndrome

Start date: April 2014
Phase: N/A
Study type: Observational

measuring serum gherlin in polycystic ovary syndrome patients and compare it to healthy levels